- Large scientific program will
reinforce the ongoing clinical and patient benefits of its robust
portfolio
- Highlights include new product
launches in phacoemulsification, visualization for the Cataract
Refractive Suite and innovations in intraoperative aberrometry and
AT-IOLs
- Onsite events for surgeons
demonstrate Alcon’s continued commitment to world-class training,
education
Regulatory News:
Alcon, the global leader in eye care dedicated to helping people
see brilliantly, will feature new clinical data along with
innovative product designs and technology for the Cataract
Refractive Suite during the American Society of Cataract and
Refractive Surgery (ASCRS) 2019 annual meeting, taking place May
3-7 in San Diego, CA. The company – which recently became an
independent, publicly-traded entity – will be included in 170
scientific abstracts at the meeting, underscoring its efforts to
support surgeons with the most complete line of ophthalmic surgical
devices.
“It’s an exciting time at Alcon. We are the largest independent
eye care device company in the world, with a powerful plan for
innovation and growth, fueled in part by the data and technology we
will be showcasing at ASCRS this year,” said Sergio Duplan, Region
President, North America, Alcon. “This meeting offers another
opportunity to demonstrate our focus in delivering advancements in
areas we know are important to our customers – especially
personalization, precision and efficiency during surgery to deliver
better patient outcomes.”
Innovating in Phacoemulsification (Phaco) Technology
In an effort to improve safety, consistency and control during
cataract surgery, Alcon will launch the ACTIVE SENTRY® Handpiece
and INTREPID® Hybrid Tip. The ACTIVE SENTRY® Handpiece is the first
and only phaco handpiece with a built-in fluidics pressure sensor
that detects pressure in real time and communicates with the
CENTURION® Vision System. The INTREPID® Hybrid Tip is an update to
the popular INTREPID® BALANCED Tip, and includes a rounded polymer
edge designed to reduce the risk of capsular tears and improve
patient safety in the OR.1 Several posters and presentations will
highlight the clinical significance of these devices.
- Monday, May 6
- Paper Presentation: Occlusion Break
Surge Volume Reduction with Active Sentry, Presented by Dr. Kevin
M. Miller (3:40 – 3:45 p.m., San Diego Convention Center [SDCC],
Upper Level, Room 1B).
- Tuesday, May 7
- Paper Presentation: Evaluation of the
Capsular Safety of a Novel Hybrid Phacoemulsification Tip in a
Cadaver Eye Model, Presented by Dr. Caleb L. Shumway, et al. (10:07
– 10:12 a.m., SDCC, Upper Level, Room 1A).
Changing the Paradigm in Visualization
Alcon will feature two technologies that aim to improve surgeon
visualization during cataract surgery.
- The new LuxOR Revalia™ Ophthalmic
Microscope delivers enhanced visualization during all stages of
cataract surgery through unique and personalized LED illumination
technology.2
- NGENUITY® 3D Visualization System will
now be available in the Cataract Refractive Suite to bring
unprecedented 3D visualization for the anterior space.3 In addition
to offering greater depth of focus during cataract surgery, the
system enables a full view of the surgical procedure for the entire
OR staff, and enhances training and teaching capabilities for
residents and fellows. It also allows the surgeon to operate with a
more ergonomic posture during surgery.4
Highlighting Advantages of Intraoperative Aberrometry
The ORA SYSTEM® powered by AnalyzOR™ Technology is the only
intraoperative aberrometer to bring precise, real-time tracking of
refractive outcomes for continual optimization during surgery. Key
data shared at the meeting will examine the results of using
intraoperative aberrometry versus pre-operative formulas.
- Saturday, May 4
- Paper Presentation: Refractive Outcomes
Using Intraoperative Aberrometry for Highly Myopic, Highly
Hyperopic, and Post-Refractive Eyes, Presented by Dr. Terry Kim, et
al. (1:45 – 1:50 p.m., SDCC, Upper Level, Room 1B).
- Tuesday, May 7
- Paper Presentation: Use of a Refractive
Analysis Database for Intraocular Lens Power Optimization in
Cataract Surgery, Presented by Dr. Robert J. Cionni et al. (9:00 –
9:05 a.m., SDCC, Upper Level, Room 1B).
Alcon will be hosting a symposium titled Intra-Operative
Aberrometry (IOA) In Modern Cataract Refractive Surgery for Current
and Future Users Summit for existing or interested ORA SYSTEM®
technology users; the symposium will focus on ORA intraoperative
aberrometry with preoperative formulas. This event will be
held on Friday, May 3 from 5:30 – 7:30 p.m., Marriott Marquis, San
Diego Marina, Ballroom 10.
Examining the Benefits of Presbyopia-Correcting IOLs
Alcon’s ReSTOR® +2.5D ACTIVEFOCUS™ is the only multifocal toric
IOL that delivers uncompromised distance vision and unrivaled
stability.5-10 New data will be presented which looks at the
satisfaction of patients implanted with a ReSTOR® 2.5 and 3.0 add
lens combination and the rotational stability with ACTIVEFOCUS™
Toric IOLs versus TECNIS® Toric IOLs*.
- Saturday, May 4
- Paper Presentation: Patient-Reported
Satisfaction and Spectacle Independence Using Mini-monovision with
the Multifocal IOLs in Cataract Surgery, Presented by Dr. John
A. Hovanesian (2:10 – 2:15 p.m., SDCC, Upper Level, Room 7B).
- Tuesday, May 7
- Paper Presentation: Residual
Astigmatism after IOL Placement: An Update in Rotational Trends,
Presented by Dr. Brent A. Kramer, et al. (10:32 – 10:37 a.m., SDCC,
Upper Level, Room 1B).
Alcon will also have the following events onsite:
- The Focal Point: Teachable Moments in
Cataract Surgery from the Alcon Experience Academy, during which
world-class surgeons will discuss cataract cases via a wide-screen,
high-definition 3D video presentation. The event will take place on
Saturday, May 4 from 6:15 – 7:45 p.m., SDCC, Hall E.
- Surgeon to Surgeon gives surgeons who
visit the Alcon booth #921 the opportunity to talk one-on-one with
other surgeons about some of the most innovative eye care
technologies in the industry.
- Alcon (ALC): Our Next Chapter lunch
event enables attendees to learn more about the new, independent
Alcon including a look at how the company plans to shape the future
of ophthalmology. This will take place on Sunday, May 5 from 11:30
– 1:00 PM, SDCC, Hall E.
Visit Alcon booth #921 to learn more and experience hands-on
demonstrations of the Alcon cataract and refractive portfolio,
including our newest innovations.
All educational content of the ASCRS•ASOA Annual Meeting is
planned by its program committee, and ASCRS•ASOA does not endorse,
promote, approve, or recommend the use of any products, devices, or
services.
About CENTURION® Vision
The CENTURION® Vision system is indicated for
emulsification, separation, irrigation, and aspiration of
cataracts, residual cortical material and lens epithelial cells,
vitreous aspiration and cutting associated with anterior
vitrectomy, bipolar coagulation, and intraocular lens injection.
Appropriate use of CENTURION® Vision System parameters and
accessories is important for successful procedures. Please refer to
the ORA SYSTEM® Operator’s Manual for a complete description of
proper use and maintenance, as well as a complete list of
contraindications, warnings and precautions.
About LuxOR Revalia™ Ophthalmic
Microscope
The LuxOR Revalia™ Ophthalmic Microscope features unique
technologies designed to optimize both anterior and posterior
procedures, providing superior visualization1 for every type of
ophthalmic surgery. As with all ophthalmic microscopes, exposure
during aphakia should be limited to reduce the risk of damage.
During aphakia, limit exposure to red reflex light to no more than
7 minutes.
About NGENUITY® 3D Visualization
System
The NGENUITY® 3D Visualization System consists of a 3D
stereoscopic, high-definition digital video camera and workstation
to provide magnified stereoscopic images of objects during
micro-surgery. It acts as an adjunct to the surgical microscope
during surgery displaying real-time images or images from
recordings. Please refer to the User Manual for a complete list of
appropriate uses, warnings and precautions.
About ORA SYSTEM® powered by
AnalyzOR™
The ORA SYSTEM® technology utilizes wavefront aberrometry data
to measure and analyze the refractive power of the eye (i.e.
sphere, cylinder, and axis measurements) to support cataract
surgical procedures. Please refer to the User Manual for a complete
list of appropriate uses, warnings and precautions.
About ReSTOR® +2.5D with
ACTIVEFOCUS™ optical design
The AcrySof® IQ ReSTOR® Posterior Chamber Intraocular Multifocal
IOLs include AcrySof® IQ ReSTOR® and AcrySof® IQ ReSTOR® Toric and
are intended for primary implantation for the visual correction of
aphakia secondary to removal of a cataractous lens in adult
patients with and without presbyopia, who desire near, intermediate
and distance vision with increased spectacle independence. In
addition, the AcrySof® IQ ReSTOR® Toric IOL is intended to correct
pre-existing astigmatism. The lenses are intended to be placed in
the capsular bag. Careful preoperative evaluation and sound
clinical judgment should be used by the surgeon to decide the
risk/benefit ratio before implanting a lens in a patient with any
of the conditions described in the Directions for Use labeling for
each IOL. Some patients may experience visual disturbances and/or
discomfort due to multifocality, especially under dim light
conditions. Prior to surgery, physicians should provide
prospective patients with a copy of the Patient Information
Brochure available from Alcon informing them of possible risks and
benefits associated with the AcrySof® IQ ReSTOR® IOLs.
Disclaimer
This press release contains “forward-looking statements” within
the meaning of the safe harbor provisions of the United States
Private Securities Litigation Reform Act of 1995. Forward-looking
statements can be identified by words such as: “anticipate,”
“intend,” “commitment,” “look forward,” “maintain,” “plan,” “goal,”
“seek,” “believe,” “project,” “estimate,” “expect,” “strategy,”
“future,” “likely,” “may,” “should,” “will” and similar references
to future periods.
Forward-looking statements are neither historical facts nor
assurances of future performance. Instead, they are based only on
our current beliefs, expectations and assumptions regarding the
future of our business, future plans and strategies, and other
future conditions. Because forward-looking statements relate to the
future, they are subject to inherent uncertainties and risks that
are difficult to predict. Some of these factors are discussed in
our filings with the United States Securities and Exchange
Commission, including our Form 20-F. In particular, our
expectations could be affected by uncertainties regarding the
success of our separation and spin-off from Novartis. Should one or
more of these uncertainties or risks materialize, or should
underlying assumptions prove incorrect, actual results may vary
materially from those anticipated. Therefore, you should not rely
on any of these forward-looking statements.
Forward-looking statements in this press release speak only as
of the date of its filing, and we assume no obligation to update
forward-looking statements as a result of new information, future
events or otherwise.
About Alcon
Alcon helps people see brilliantly. As the global leader in eye
care with a heritage spanning more than seven decades, we offer the
broadest portfolio of products to enhance sight and improve
people’s lives. Our Surgical and Vision Care products touch the
lives of more than 260 million people in over 140 countries each
year living with conditions like cataracts, glaucoma, retinal
diseases and refractive errors. Our more than 20,000 associates are
enhancing the quality of life through innovative products,
partnerships with eye care professionals and programs that advance
access to quality eye care. Learn more at www.alcon.com.
Connect with us onFacebookLinkedIn
References
- Alcon Data on File.
- Alcon Data on File.
- Alcon Data on File. Yin L, Sarangapani
R. Assessment of visual attributes for NGENUITY® 3D Visualization
System 1.0 for digitally assisted vitreoretinal surgery. Alcon
Modeling and Simulation. December 2017.
- Eckardt C, Paulo EB. HEADS-UP SURGERY
FOR VITREORETINAL PROCEDURES: An Experimental and Clinical Study.
Retina. 2016 Jan;36(1):137–47.
- Alcon Data on File (Jul 2016).
- AcrySof® IQ ReSTOR® +2.5 D Multifocal
Toric IOL Directions for Use.
- Vega F, Alba-Bueno F, Millán MS, Varon
C, Gil MA, Buil JA. Halo and through-focus performance of four
diffractive multifocal intraocular lenses. Invest Ophthalmol Vis
Sci. 2015;56(6):3967-3975 (study conducted with corneal model eye
with 0.28μ spherical aberration).
- Wirtitsch MG, Findl O, Menapace R, et
al. Effect of haptic design on change in axial lens position after
cataract surgery. J Cataract Refract Surg. 2004;30(1):45-51.
- Visser N, Bauer NJ, Nuijts RM. Toric
intra-ocular lenses: historical overview, patient selection, IOL
calculation, surgical techniques, clinical outcomes, and
complications. J Cataract Refract Surg. 2013;39(4):624-637.
- Potvin R, Kramer BA, Hardten DR,
Berdahl JP. Toric intraocular lens orientation and residual
refractive astigmatism: an analysis. Clin Ophthalmol.
2016;10;1829-1836.
* TECNIS® is a registered trademark of Johnson &
Johnson.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20190501005240/en/
Media RelationsBlake
Overby+1 817 551 4328 (office)+1 682 321
2897Blake-1.overby@alcon.com
Investor RelationsChristina
Cheng+ 1 41 589 112 110 (Geneva)+ 1 817 615 2789 (Fort
Worth)investor.relations@alcon.com
Alcon (NYSE:ALC)
Historical Stock Chart
From Jun 2024 to Jul 2024
Alcon (NYSE:ALC)
Historical Stock Chart
From Jul 2023 to Jul 2024